首页 > 最新文献

European Annals of Otorhinolaryngology-Head and Neck Diseases最新文献

英文 中文
Optimization of the automated Sunnybrook Facial Grading System - Improving the reliability of a deep learning network with facial landmarks. 优化桑尼布鲁克面部自动分级系统--利用面部地标提高深度学习网络的可靠性。
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-07 DOI: 10.1016/j.anorl.2024.07.005
T C Ten Harkel, F Bielevelt, H A M Marres, K J A O Ingels, T J J Maal, C M Speksnijder

Objective: The Sunnybrook Facial Grading System (SFGS) is a well-established grading system to assess the severity and progression of a unilateral facial palsy. The automation of the SFGS makes the SFGS more accessible for researchers, students, clinicians in training, or other untrained co-workers and could be implemented in an eHealth environment. This study investigated the impact on the reliability of the automated SFGS by adding a facial landmark layer in a previously developed convolutional neural network (CNN).

Methods: An existing dataset of 116 patients with a unilateral peripheral facial palsy and 9 healthy subjects performing the SFGS poses was used to train a CNN with a newly added facial landmark layer. A separate model was trained for each of the 13 elements of the SFGS and then used to calculate the SFGS subscores and composite score. The intra-class coefficient of the automated grading system was calculated based on three clinicians experienced in the grading of facial palsy.

Results: The inter-rater reliability of the CNN with the additional facial landmarks increased in performance for all composite scores compared to the previous model. The intra-class coefficient for the composite SFGS score increased from 0.87 to 0.91, the resting symmetry subscore increased from 0.45 to 0.62, the symmetry of voluntary movement subscore increased from 0.89 to 0.92, and the synkinesis subscore increased from 0.75 to 0.78.

Conclusion: The integration of a facial landmark layer into the CNN significantly improved the reliability of the automated SFGS, reaching a performance level comparable to human observers. These results were attained without increasing the dataset underscoring the impact of incorporating facial landmarks into a CNN. These findings indicate that the automated SFGS with facial landmarks is a reliable tool for assessing patients with a unilateral peripheral facial palsy and is applicable in an eHealth environment.

目的:桑尼布鲁克面瘫分级系统(SFGS)是一套成熟的分级系统,用于评估单侧面瘫的严重程度和进展情况。SFGS 的自动化使研究人员、学生、接受培训的临床医生或其他未经培训的同事更容易使用 SFGS,并可在电子健康环境中实施。本研究调查了在先前开发的卷积神经网络(CNN)中添加面部地标层对自动 SFGS 可靠性的影响:方法:使用一个包含 116 名单侧周围性面瘫患者和 9 名健康受试者的现有数据集来训练带有新添加的面部地标层的 CNN。针对 SFGS 的 13 个元素分别训练了一个单独的模型,然后用于计算 SFGS 的子分数和综合分数。根据三位在面瘫分级方面经验丰富的临床医生计算出了自动分级系统的类内系数:结果:与之前的模型相比,增加了面部地标的 CNN 在所有综合评分方面的评分者间可靠性都有所提高。SFGS 综合评分的类内系数从 0.87 增加到 0.91,静息对称性子评分从 0.45 增加到 0.62,自主运动对称性子评分从 0.89 增加到 0.92,同步运动子评分从 0.75 增加到 0.78:将面部地标层整合到 CNN 中可显著提高自动 SFGS 的可靠性,达到与人类观察者相当的性能水平。这些结果是在不增加数据集的情况下取得的,凸显了将面部地标纳入 CNN 的影响。这些研究结果表明,带有面部地标的自动 SFGS 是评估单侧周围性面瘫患者的可靠工具,适用于电子健康环境。
{"title":"Optimization of the automated Sunnybrook Facial Grading System - Improving the reliability of a deep learning network with facial landmarks.","authors":"T C Ten Harkel, F Bielevelt, H A M Marres, K J A O Ingels, T J J Maal, C M Speksnijder","doi":"10.1016/j.anorl.2024.07.005","DOIUrl":"https://doi.org/10.1016/j.anorl.2024.07.005","url":null,"abstract":"<p><strong>Objective: </strong>The Sunnybrook Facial Grading System (SFGS) is a well-established grading system to assess the severity and progression of a unilateral facial palsy. The automation of the SFGS makes the SFGS more accessible for researchers, students, clinicians in training, or other untrained co-workers and could be implemented in an eHealth environment. This study investigated the impact on the reliability of the automated SFGS by adding a facial landmark layer in a previously developed convolutional neural network (CNN).</p><p><strong>Methods: </strong>An existing dataset of 116 patients with a unilateral peripheral facial palsy and 9 healthy subjects performing the SFGS poses was used to train a CNN with a newly added facial landmark layer. A separate model was trained for each of the 13 elements of the SFGS and then used to calculate the SFGS subscores and composite score. The intra-class coefficient of the automated grading system was calculated based on three clinicians experienced in the grading of facial palsy.</p><p><strong>Results: </strong>The inter-rater reliability of the CNN with the additional facial landmarks increased in performance for all composite scores compared to the previous model. The intra-class coefficient for the composite SFGS score increased from 0.87 to 0.91, the resting symmetry subscore increased from 0.45 to 0.62, the symmetry of voluntary movement subscore increased from 0.89 to 0.92, and the synkinesis subscore increased from 0.75 to 0.78.</p><p><strong>Conclusion: </strong>The integration of a facial landmark layer into the CNN significantly improved the reliability of the automated SFGS, reaching a performance level comparable to human observers. These results were attained without increasing the dataset underscoring the impact of incorporating facial landmarks into a CNN. These findings indicate that the automated SFGS with facial landmarks is a reliable tool for assessing patients with a unilateral peripheral facial palsy and is applicable in an eHealth environment.</p>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bilateral cochlear fibrosis complicating chronic myeloid leukemia: A CARE case report. 慢性髓性白血病并发双侧耳蜗纤维化:CARE病例报告
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-07 DOI: 10.1016/j.anorl.2024.07.003
G Lahlou, H Daoudi, C Djian, I Mosnier

Purpose: We report the second case of bilateral sudden sensorineural hearing loss with intracochlear fibrosis due to chronic myeloid leukemia.

Case report: A 44-year-old man presented to the emergency department with rapidly progressive bilateral hearing loss, tinnitus and vertigo, associated with dyspnea. Chronic myeloid leukemia complicated by pulmonary and cochleovestibular leukostasis was diagnosed, and cytoreductive treatment was started. Despite this treatment, bilateral total hearing loss and complete vestibular deficit persisted. MRI showed bilateral labyrinthitis, and emergency cochlear implantation was indicated. During surgery, inflammatory intracochlear tissue made electrode array insertion possible only against resistance. One year after implantation, there was significant improvement in speech recognition and communication scores.

Conclusion: In case of sudden sensorineural hearing loss induced by chronic myeloid leukemia, treatment should be as fast as possible, with prompt cochlear implantation in case of definitive profound hearing loss, because of the risk of cochlear fibrosis and ossification.

目的:我们报告了第二例慢性髓性白血病导致的双侧突发性感音神经性听力损失并伴有耳蜗内纤维化的病例:一名 44 岁男子因双侧听力急剧下降、耳鸣和眩晕并伴有呼吸困难到急诊科就诊。确诊为慢性髓性白血病,并发肺和耳蜗白血病,并开始进行细胞再生治疗。尽管进行了治疗,但双侧听力完全丧失和前庭完全缺损的情况依然存在。磁共振成像显示患者患有双侧耳迷路炎,因此需要紧急植入人工耳蜗。手术过程中,由于耳蜗内组织发炎,电极阵列的插入受到阻力。植入手术一年后,患者的语言识别能力和交流能力显著提高:结论:对于慢性粒细胞白血病诱发的突发性感音神经性听力损失,由于存在耳蜗纤维化和骨化的风险,应尽快进行治疗,并在出现明确的深度听力损失时及时植入人工耳蜗。
{"title":"Bilateral cochlear fibrosis complicating chronic myeloid leukemia: A CARE case report.","authors":"G Lahlou, H Daoudi, C Djian, I Mosnier","doi":"10.1016/j.anorl.2024.07.003","DOIUrl":"https://doi.org/10.1016/j.anorl.2024.07.003","url":null,"abstract":"<p><strong>Purpose: </strong>We report the second case of bilateral sudden sensorineural hearing loss with intracochlear fibrosis due to chronic myeloid leukemia.</p><p><strong>Case report: </strong>A 44-year-old man presented to the emergency department with rapidly progressive bilateral hearing loss, tinnitus and vertigo, associated with dyspnea. Chronic myeloid leukemia complicated by pulmonary and cochleovestibular leukostasis was diagnosed, and cytoreductive treatment was started. Despite this treatment, bilateral total hearing loss and complete vestibular deficit persisted. MRI showed bilateral labyrinthitis, and emergency cochlear implantation was indicated. During surgery, inflammatory intracochlear tissue made electrode array insertion possible only against resistance. One year after implantation, there was significant improvement in speech recognition and communication scores.</p><p><strong>Conclusion: </strong>In case of sudden sensorineural hearing loss induced by chronic myeloid leukemia, treatment should be as fast as possible, with prompt cochlear implantation in case of definitive profound hearing loss, because of the risk of cochlear fibrosis and ossification.</p>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141908080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lymph node surgery for salivary gland cancer: REFCOR recommendations by the formal consensus method 淋巴结手术治疗唾液腺癌:REFCOR推荐的正式共识方法。
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.anorl.2023.11.001

Objective

To determine the indications for neck dissection in the management of parotid, submandibular or minor salivary gland cancers depending on the clinical situation: i.e., clinical lymph node involvement (cN+) or not (cN0); low or high risk of occult nodal metastasis; diagnosis of malignancy before, during or after surgery.

Material and methods

The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group which drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group according to the formal consensus method.

Results

In cN+ salivary gland cancer, ipsilateral neck dissection is recommended. In cN0 salivary gland cancer, ipsilateral neck dissection is recommended, except for tumors at low risk of occult nodal metastasis. If definitive pathology reveals a high risk of occult nodal involvement, additional neck treatment is recommended: ipsilateral neck dissection or elective nodal irradiation.

Conclusion

The rate of occult lymph node involvement, and therefore the indication for elective neck dissection, depends primarily on the pathologic grade of the salivary gland cancer.

目的:根据临床情况,即临床淋巴结累及(cN+)与否(cN0),确定腮腺癌、颌下腺癌或小唾液腺癌的颈部清扫指征;隐匿性淋巴结转移风险低或高;手术前、手术中或手术后的恶性肿瘤诊断。材料和方法:法国罕见头颈部肿瘤网络(REFCOR)成立了一个指导小组,起草了Medline上发表的文献的叙述性综述,并提出了建议。然后由一个评级小组根据正式的共识方法评估对建议的遵守程度。结果:cN+涎腺癌建议行同侧颈部清扫术。在cN0唾液腺癌中,除了低风险隐匿淋巴结转移的肿瘤外,建议进行同侧颈部清扫。如果明确的病理显示隐匿性淋巴结受累率高,建议进行额外的颈部治疗:同侧颈部清扫或选择性淋巴结照射。结论:涎腺癌的病理分级决定了隐匿淋巴结受累率以及择期颈淋巴清扫的指征。
{"title":"Lymph node surgery for salivary gland cancer: REFCOR recommendations by the formal consensus method","authors":"","doi":"10.1016/j.anorl.2023.11.001","DOIUrl":"10.1016/j.anorl.2023.11.001","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the indications for neck dissection in the management of parotid, submandibular or minor salivary gland cancers depending on the clinical situation: i.e., clinical lymph node involvement (cN+) or not (cN0); low or high risk of occult nodal metastasis; diagnosis of malignancy before, during or after surgery.</p></div><div><h3>Material and methods</h3><p>The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group which drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group according to the formal consensus method.</p></div><div><h3>Results</h3><p>In cN+ salivary gland cancer, ipsilateral neck dissection is recommended. In cN0 salivary gland cancer, ipsilateral neck dissection is recommended, except for tumors at low risk of occult nodal metastasis. If definitive pathology reveals a high risk of occult nodal involvement, additional neck treatment is recommended: ipsilateral neck dissection or elective nodal irradiation.</p></div><div><h3>Conclusion</h3><p>The rate of occult lymph node involvement, and therefore the indication for elective neck dissection, depends primarily on the pathologic grade of the salivary gland cancer.</p></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138463795","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Analysis of endonasal sinus surgery in a private outpatient setting in a tropical environment: A STROBE analysis 热带环境下私人门诊鼻窦内窥镜手术分析:STROBE 分析。
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.anorl.2024.02.006

Objectives

To evaluate results and failure factors in endonasal surgery in a private outpatient setting in a tropical environment.

Material and method

A single-center observational study included 337 patients consecutively undergoing endonasal surgery in a private hospital on Réunion Island, a French overseas administrative Département in the Indian Ocean between 2019 and 2021. The main objective was to assess the success rate of the outpatient pathway. Secondary objectives comprised analysis of complications and identification and management of factors for failure of outpatient management. The study was conducted according to the STROBE editorial guideline.

Results

The 337 surgeries notably comprised 112 septoplasties (37.5%), 104 meatotomies (30.3%), 15 unilateral total ethmoidectomies (4.6%), 48 bilateral total ethmoidectomies with sphenoidotomy (14.3%), and 18 Draf procedures (5.5%). Seventy-five percent of patients (252/337) were operated on as outpatients, with a success rate of 90% (227/252 patients). The rate of severe intraoperative complications was 1.5% (5/337). On multivariate analysis, 3 variables were identified as influencing risk of failure of the outpatient pathway: emergency analgesia in the operating room [odds ratio (OR): 91.61; 95% confidence interval (CI): 22.8–540.3], operating time (OR: 1.05; 95% CI: 1.01–1.09), and recovery room time (OR: 1.02; 95% CI: 1.01–1.03).

Conclusion

Our study in a tropical environment found eligibility and success rates for outpatient endonasal surgery similar to those in metropolitan France. This makes surgical and anesthesiological training a key factor in the success of outpatient care, while the location of the care structure and the climate seem to have little impact.

目的评估热带环境下私立门诊鼻内镜手术的结果和失败因素:这是一项单中心观察性研究,纳入了2019年至2021年期间在留尼汪岛(印度洋上的法国海外行政区)一家私立医院连续接受鼻内镜手术的337名患者。主要目的是评估门诊路径的成功率。次要目标包括并发症分析以及门诊治疗失败因素的识别和管理。研究根据 STROBE 编辑指南进行:值得注意的是,337例手术包括112例鼻中隔成形术(37.5%)、104例切肉术(30.3%)、15例单侧全乙状舌骨切除术(4.6%)、48例双侧全乙状舌骨切除术(14.3%)和18例Draf手术(5.5%)。75%的患者(252/337)在门诊接受手术,成功率为90%(227/252)。术中严重并发症发生率为 1.5%(5/337)。通过多变量分析,确定了影响门诊路径失败风险的三个变量:手术室紧急镇痛[几率比(OR):91.61;95% 置信区间(CI):22.8-540.3]、手术时间(OR:1.05;95% CI:1.01-1.09)和恢复室时间(OR:1.02;95% CI:1.01-1.03):我们在热带环境中进行的研究发现,门诊鼻内手术的合格率和成功率与法国本土相似。因此,手术和麻醉培训是门诊治疗成功的关键因素,而医疗机构的位置和气候似乎影响不大。
{"title":"Analysis of endonasal sinus surgery in a private outpatient setting in a tropical environment: A STROBE analysis","authors":"","doi":"10.1016/j.anorl.2024.02.006","DOIUrl":"10.1016/j.anorl.2024.02.006","url":null,"abstract":"<div><h3>Objectives</h3><p>To evaluate results and failure factors in endonasal surgery in a private outpatient setting in a tropical environment.</p></div><div><h3>Material and method</h3><p>A single-center observational study included 337 patients consecutively undergoing endonasal surgery in a private hospital on Réunion Island, a French overseas administrative <em>Département</em> in the Indian Ocean between 2019 and 2021. The main objective was to assess the success rate of the outpatient pathway. Secondary objectives comprised analysis of complications and identification and management of factors for failure of outpatient management. The study was conducted according to the STROBE editorial guideline.</p></div><div><h3>Results</h3><p><span>The 337 surgeries notably comprised 112 septoplasties<span> (37.5%), 104 meatotomies (30.3%), 15 unilateral total ethmoidectomies (4.6%), 48 bilateral total ethmoidectomies with sphenoidotomy (14.3%), and 18 Draf procedures (5.5%). Seventy-five percent of patients (252/337) were operated on as outpatients, with a success rate of 90% (227/252 patients). The rate of severe </span></span>intraoperative complications<span> was 1.5% (5/337). On multivariate analysis<span>, 3 variables were identified as influencing risk of failure of the outpatient pathway: emergency analgesia in the operating room [odds ratio (OR): 91.61; 95% confidence interval (CI): 22.8–540.3], operating time (OR: 1.05; 95% CI: 1.01–1.09), and recovery room time (OR: 1.02; 95% CI: 1.01–1.03).</span></span></p></div><div><h3>Conclusion</h3><p>Our study in a tropical environment found eligibility and success rates for outpatient endonasal surgery similar to those in metropolitan France. This makes surgical and anesthesiological training a key factor in the success of outpatient care, while the location of the care structure and the climate seem to have little impact.</p></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139944568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dangers and therapeutic difficulties of intracranial hemangioma in infants: A CARE case report 婴儿颅内血管瘤的危害和治疗困难:CARE病例报告。
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.anorl.2024.02.001

Introduction

Description of neurological complications induced by intracranial hemangioma in infants and by the initiation of beta-blocker treatment (propranolol).

Observation

A 2-month-old infant was referred for grade 5 non-congenital unilateral peripheral facial palsy. Work-up revealed ipsilateral profound hearing loss and two intracranial hemangiomas: one in the ipsilateral internal auditory canal (IAC), the other in the cerebellum opposite the nodule of vermis. Initial treatment with a beta-blocker (propranolol 1 mg/kg/day for 1 month, then 3 mg/kg/day) resulted in disappearance of symptoms and regression of lesions within 8 weeks. At 20 months after introduction of maintenance therapy (propranolol 3 mg/kg/day), two asthma attacks occurred, leading to initiation of fluticasone and continuation of the beta-blocker. Thirty months after discontinuation of treatment, no further progression was noted.

Discussion

Unilateral facial palsy in an infant suggests a number of diagnoses. MRI revealed IAC hemangioma. The choice of dosage and duration of treatment was based on a review of the literature and a strategy defined in multidisciplinary consultation.

简介:描述婴儿颅内血管瘤和开始使用β-受体阻滞剂(普萘洛尔)治疗引起的神经并发症:描述婴儿颅内血管瘤和开始使用β-受体阻滞剂(普萘洛尔)治疗后引起的神经系统并发症:一名 2 个月大的婴儿因 5 级非先天性单侧周围性面瘫而转诊。检查发现婴儿同侧听力严重受损,并有两个颅内血管瘤:一个位于同侧内耳道(IAC),另一个位于蚓部结节对面的小脑。最初使用β-受体阻滞剂(普萘洛尔 1 毫克/千克/天,持续 1 个月,然后 3 毫克/千克/天)治疗,结果在 8 周内症状消失,病变消退。在接受维持治疗(普萘洛尔 3 毫克/千克/天)20 个月后,哮喘发作了两次,因此开始使用氟替卡松,并继续使用β-受体阻滞剂。停止治疗 30 个月后,病情没有进一步发展:讨论:婴儿单侧面瘫有多种诊断可能。核磁共振成像显示为 IAC 血管瘤。根据文献综述和多学科会诊确定的策略,选择了治疗剂量和疗程。
{"title":"Dangers and therapeutic difficulties of intracranial hemangioma in infants: A CARE case report","authors":"","doi":"10.1016/j.anorl.2024.02.001","DOIUrl":"10.1016/j.anorl.2024.02.001","url":null,"abstract":"<div><h3>Introduction</h3><p>Description of neurological complications<span> induced by intracranial hemangioma in infants and by the initiation of beta-blocker treatment (propranolol).</span></p></div><div><h3>Observation</h3><p><span><span><span>A 2-month-old infant was referred for grade 5 non-congenital unilateral peripheral facial palsy. Work-up revealed ipsilateral profound hearing loss and two intracranial hemangiomas: one in the ipsilateral </span>internal auditory canal (IAC), the other in the </span>cerebellum opposite the nodule of vermis. Initial treatment with a beta-blocker (propranolol 1</span> <!-->mg/kg/day for 1<!--> <!-->month, then 3<!--> <!-->mg/kg/day) resulted in disappearance of symptoms and regression of lesions within 8<!--> <!-->weeks. At 20<!--> <!-->months after introduction of maintenance therapy (propranolol 3<!--> <span>mg/kg/day), two asthma attacks occurred, leading to initiation of fluticasone and continuation of the beta-blocker. Thirty months after discontinuation of treatment, no further progression was noted.</span></p></div><div><h3>Discussion</h3><p>Unilateral facial palsy in an infant suggests a number of diagnoses. MRI revealed IAC hemangioma. The choice of dosage and duration of treatment was based on a review of the literature and a strategy defined in multidisciplinary consultation.</p></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139941056","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Costs analysis of cochlear implantation in children 儿童人工耳蜗植入的成本分析。
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.anorl.2024.02.012

Objectives

The study assessed the direct medical costs of the cochlear implantation pathway from the healthcare payer's perspective, in children with bilateral severe to profound hearing loss, from diagnosis to 3 years’ follow-up after first implantation. We also compared costs between two populations: congenital and progressive deafness.

Material and methods

A retrospective costs analysis was performed for 56 children who received a cochlear implant in one French pediatric ENT center. The children had severe to profound hearing loss, and were implanted before the age of 10 years. We calculated direct medical costs in 3 phases: diagnosis to pre-implantation assessment, surgical and hospital management of implantation, and 3 years’ follow-up.

Results

Mean costs were €64,675 (range, €38,709–113,954) per child from diagnosis to 3 years after first implantation. Mean costs in congenital deafness detected on neonatal screening and on progressive deafness were respectively €65,420 and €63,930 (P = 0.7).

Conclusion

The global cost was €64,675 per child from diagnosis to 3 years after first implantation. There was no difference in cost according to congenital versus progressive hearing loss.

研究目的:本研究从医疗支付方的角度评估了双侧重度至极重度听力损失儿童从诊断到首次植入后 3 年随访期间人工耳蜗植入途径的直接医疗成本。我们还比较了先天性耳聋和进行性耳聋两种人群的费用:我们对在法国一家儿科耳鼻喉科中心接受人工耳蜗植入手术的 56 名儿童进行了回顾性成本分析。这些儿童都患有重度至极重度听力损失,并且在 10 岁之前植入了人工耳蜗。我们计算了三个阶段的直接医疗成本:从诊断到植入前评估、植入手术和住院管理以及三年的随访:每个儿童从诊断到首次植入后 3 年的平均费用为 64,675 欧元(范围为 38,709-113,954 欧元)。新生儿筛查发现的先天性耳聋和进行性耳聋的平均费用分别为 65,420 欧元和 63,930 欧元(P=0.7):结论:每名儿童从诊断到首次植入耳蜗后 3 年的总费用为 64,675 欧元。先天性听力损失与进行性听力损失的成本没有差异。
{"title":"Costs analysis of cochlear implantation in children","authors":"","doi":"10.1016/j.anorl.2024.02.012","DOIUrl":"10.1016/j.anorl.2024.02.012","url":null,"abstract":"<div><h3>Objectives</h3><p>The study assessed the direct medical costs of the cochlear implantation pathway from the healthcare payer's perspective, in children with bilateral severe to profound hearing loss, from diagnosis to 3 years’ follow-up after first implantation. We also compared costs between two populations: congenital and progressive deafness.</p></div><div><h3>Material and methods</h3><p>A retrospective costs analysis was performed for 56 children who received a cochlear implant in one French pediatric ENT center. The children had severe to profound hearing loss, and were implanted before the age of 10 years. We calculated direct medical costs in 3 phases: diagnosis to pre-implantation assessment, surgical and hospital management of implantation, and 3 years’ follow-up.</p></div><div><h3>Results</h3><p>Mean costs were €64,675 (range, €38,709–113,954) per child from diagnosis to 3 years after first implantation. Mean costs in congenital deafness detected on neonatal screening and on progressive deafness were respectively €65,420 and €63,930 (<em>P</em> <!-->=<!--> <!-->0.7).</p></div><div><h3>Conclusion</h3><p>The global cost was €64,675 per child from diagnosis to 3 years after first implantation. There was no difference in cost according to congenital versus progressive hearing loss.</p></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1879729624000292/pdfft?md5=34ef112d5741091e5e6b6eb5e2af1ba6&pid=1-s2.0-S1879729624000292-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiotherapy for salivary gland cancer: REFCOR recommendations by the formal consensus method 唾液腺癌的放射治疗:REFCOR推荐的正式共识方法。
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.anorl.2023.11.006

Objective

To determine the indications for radiotherapy in salivary gland cancer and to specify the modalities and target radiation volumes.

Material and methods

The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group which drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group, according to the formal consensus method.

Results

Postoperatively, radiotherapy to the primary tumor site ± to the lymph nodes is indicated if one or more of the following adverse histoprognostic factors are present (risk > 10% of locoregional recurrence): T3–T4 category, lymph node invasion, extraglandular invasion, close or positive surgical margins, high tumor grade, perineural invasion, vascular emboli, and/or bone invasion. Intensity-modulated radiation therapy (IMRT) is the gold standard. For unresectable cancers or inoperable patients, carbon ion hadrontherapy may be considered.

Conclusion

Radiotherapy in salivary gland cancer is indicated in postoperative situations in case of adverse histoprognostic factors and for inoperable tumors.

目的:探讨涎腺癌放射治疗的适应证,明确放射治疗的方式和靶量。材料和方法:法国罕见头颈部肿瘤网络(REFCOR)成立了一个指导小组,起草了Medline上发表的文献的叙述性综述,并提出了建议。然后,根据正式的共识方法,由一个评级小组评估对建议的遵守程度。结果:术后,如果存在以下一个或多个不良组织预后因素(局部复发的风险>10%),则需要对原发肿瘤部位±淋巴结进行放射治疗:T3-T4类别,淋巴结浸润,腺外浸润,手术边缘闭合或阳性,肿瘤分级高,神经周围浸润,血管栓塞,和/或骨浸润。调强放射治疗(IMRT)是金标准。对于不能切除的癌症或不能手术的患者,可以考虑碳离子强子疗法。结论:涎腺癌在术后组织预后不良及不能手术的肿瘤时,应采用放射治疗。
{"title":"Radiotherapy for salivary gland cancer: REFCOR recommendations by the formal consensus method","authors":"","doi":"10.1016/j.anorl.2023.11.006","DOIUrl":"10.1016/j.anorl.2023.11.006","url":null,"abstract":"<div><h3>Objective</h3><p>To determine the indications for radiotherapy in salivary gland cancer and to specify the modalities and target radiation volumes.</p></div><div><h3>Material and methods</h3><p>The French Network of Rare Head and Neck Tumors (REFCOR) formed a steering group which drafted a narrative review of the literature published on Medline and proposed recommendations. The level of adherence to the recommendations was then assessed by a rating group, according to the formal consensus method.</p></div><div><h3>Results</h3><p>Postoperatively, radiotherapy to the primary tumor site<!--> <!-->±<!--> <!-->to the lymph nodes is indicated if one or more of the following adverse histoprognostic factors are present (risk<!--> <!-->&gt;<!--> <!-->10% of locoregional recurrence): T3–T4 category, lymph node invasion, extraglandular invasion, close or positive surgical margins, high tumor grade, perineural invasion, vascular emboli, and/or bone invasion. Intensity-modulated radiation therapy (IMRT) is the gold standard. For unresectable cancers or inoperable patients, carbon ion hadrontherapy may be considered.</p></div><div><h3>Conclusion</h3><p>Radiotherapy in salivary gland cancer is indicated in postoperative situations in case of adverse histoprognostic factors and for inoperable tumors.</p></div>","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138463797","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An unusual aural fullness 不同寻常的听觉饱满度
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.anorl.2024.02.004
{"title":"An unusual aural fullness","authors":"","doi":"10.1016/j.anorl.2024.02.004","DOIUrl":"10.1016/j.anorl.2024.02.004","url":null,"abstract":"","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140013523","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The “right” track! 正确的 "轨道
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.anorl.2023.11.010
{"title":"The “right” track!","authors":"","doi":"10.1016/j.anorl.2023.11.010","DOIUrl":"10.1016/j.anorl.2023.11.010","url":null,"abstract":"","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139677785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ranula at the dawn of the French Republic 法兰西共和国初创时期的拉努拉
IF 1.9 4区 医学 Q2 OTORHINOLARYNGOLOGY Pub Date : 2024-08-01 DOI: 10.1016/j.anorl.2024.04.004
{"title":"Ranula at the dawn of the French Republic","authors":"","doi":"10.1016/j.anorl.2024.04.004","DOIUrl":"10.1016/j.anorl.2024.04.004","url":null,"abstract":"","PeriodicalId":48834,"journal":{"name":"European Annals of Otorhinolaryngology-Head and Neck Diseases","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1879729624000553/pdfft?md5=eabc607ef9f729b0c6aed631559cd17c&pid=1-s2.0-S1879729624000553-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873287","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Annals of Otorhinolaryngology-Head and Neck Diseases
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1